Existing Users Log In
   

Breast surgery indication in MBC.

🎙️ Exploring Impact of Breast Surgery on Metastatic Breast Cancer: Insights from BCU 2022

At BCU 2023, Rita SAKR delivered a compelling lecture on the complex topic: role of breast surgery in metastatic breast cancer. Since 2002, an array of retrospective non-randomized clinical studies has highlighted the potential connection between primary tumor removal and enhanced survival in primary MBC patients.

🔍 However, the narrative becomes nuanced when considering the possible influence of selection biases on the observed survival benefit associated with surgery. This highlight the need for randomized controlled trials (RCTs) for a clearer understanding.

📊 The results from these trials offer a mosaic of insights. While surgical intervention exhibited an improvement in local progression-free survival, the story took an unexpected turn as it seemed to cast a shadow on distant progression-free survival.

🤝 The challenge lies in drawing definitive conclusions from these divergent findings. Rita SAKR rightly underscores the need for well-conducted RCTs boasting larger sample sizes. These trials are the linchpin in validating and solidifying the observations garnered from observational studies.

🔬 The journey to comprehending the intricacies of breast surgery’s impact on metastatic breast cancer marches on, propelled by rigorous research and a determination to improve patient outcomes.

Rita SAKR is a French / European Board certified, American Fellow, Breast Oncoplastic Surgeon & Ob-Gynecologist with over 20 years of surgical, clinical, academic and research experience in the field. Director of the Breast Clinic at Kings College Hospital, Dubai

Text generated by AI based on an exclusive interview, revised and reviewed by

  • October 20, 2023